Two Nuclear Localization Signals in USP1 Mediate Nuclear Import of the USP1/UAF1 Complex

被引:30
|
作者
Garcia-Santisteban, Iraia [1 ]
Zorroza, Kerman [2 ]
Antonio Rodriguez, Jose [1 ]
机构
[1] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain
[2] Basque Fdn Hlth Innovat & Res, BioEF, Bilbao, Spain
来源
PLOS ONE | 2012年 / 7卷 / 06期
关键词
FANCONI-ANEMIA PATHWAY; UBIQUITIN SYSTEM; PROTEIN; EXPORT; CANCER; REPAIR; DEUBIQUITINATION; IDENTIFICATION; SEQUENCE; REVERSE;
D O I
10.1371/journal.pone.0038570
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The human deubiquitinase USP1 plays important roles in cancer-related processes, such as the DNA damage response, and the maintenance of the undifferentiated state of osteosarcoma cells. USP1 deubiquitinase activity is critically regulated by its interaction with the WD40 repeat-containing protein UAF1. Inhibiting the function of the USP1/UAF1 complex sensitizes cancer cells to chemotherapy, suggesting that this complex is a relevant anticancer target. Intriguingly, whereas UAF1 has been reported to locate in the cytoplasm, USP1 is a nuclear protein, although the sequence motifs that mediate its nuclear import have not been functionally characterized. Here, we identify two nuclear localization signals (NLSs) in USP1 and show that these NLSs mediate the nuclear import of the USP1/UAF1 complex. Using a cellular relocation assay based on these results, we map the UAF1-binding site to a highly conserved 100 amino acid motif in USP1. Our data support a model in which USP1 and UAF1 form a complex in the cytoplasm that subsequently translocates to the nucleus through import mediated by USP1 NLSs. Importantly, our findings have practical implications for the development of USP1-directed therapies. First, the UAF1-interacting region of USP1 identified here might be targeted to disrupt the USP1/UAF1 interaction with therapeutic purposes. On the other hand, we describe a cellular relocation assay that can be easily implemented in a high throughput setting to search for drugs that may dissociate the USP1/UAF1 complex.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis
    Liu, Dongyi
    Li, Quanhui
    Zang, Yifeng
    Li, Xin
    Li, Zhongbo
    Zhang, Peng
    Feng, Chang
    Yang, Penghe
    Cui, Jiayao
    Sun, Yanan
    Wei, Tian
    Su, Peng
    Zhao, Xin
    Yang, Huijie
    Ding, Yinlu
    CELL DEATH & DISEASE, 2023, 14 (04)
  • [42] 鸡USP1基因的克隆及原核表达
    赵程程
    郑海南
    吴山力
    吴涵
    张玉静
    艾永兴
    畜牧与兽医, 2012, (S1) : 309 - 310
  • [43] Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 Inhibitors
    Zhang, Junjie
    Liu, Benjin
    Ren, Ruyue
    Song, Shanshan
    Bao, Xubin
    Huan, Xiajuan
    Li, Hongrui
    Xu, Jiahao
    Yu, Ting
    Wang, Ruifeng
    Miao, Ze-Hong
    Xiong, Bing
    He, Jinxue
    Liu, Tongchao
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (03) : 3673 - 3699
  • [44] TARGETING USP1 DECREASES GLIOMA STEM CELL SURVIVAL AND TUMOR GROWTH
    Kim, Eunhee
    Woo, Dong-Hun
    Oh, Youngtak
    Kim, Misuk
    Nam, Do-Hyun
    Lee, Jeongwu
    NEURO-ONCOLOGY, 2012, 14 : 149 - 149
  • [45] Identification of Debio 0432 as a potent and selective USP1 inhibitor for cancer therapy
    Luong, Noemie
    Kunze, Annett
    Quesnot, Nicolas
    Aho, Erin R.
    Berry, Loren
    Boiko, Scott
    Buckmelter, Alex J.
    Lofek, Sebastien
    Vigano, Selena
    Chardonnens, Christophe
    CANCER RESEARCH, 2024, 84 (06)
  • [46] Targeting USP1 decreases glioblastoma stem cell survival and tumor growth
    Oh, Young Taek M.
    Kim, Eunhee
    Lee, Jeongwu
    Nam, Do-Hyun
    CANCER RESEARCH, 2013, 73 (08)
  • [47] The Role of the Complex USP1/WDR48 in Differentiation and Proliferation Processes in Cancer Stem Cells
    Goncalves, Jussara Maria
    Rodriguez Cordeiro, Mabel Mariela
    Correa Rivero, Elena Riet
    CURRENT STEM CELL RESEARCH & THERAPY, 2017, 12 (05) : 416 - 422
  • [48] Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells
    Mistry, Helena
    Hsieh, Grace
    Buhrlage, Sara J.
    Huang, Min
    Park, Eunmi
    Cuny, Gregory D.
    Galinsky, Ilene
    Stone, Richard M.
    Gray, Nathanael S.
    D'Andrea, Alan D.
    Parmar, Kalindi
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (12) : 2651 - 2662
  • [49] USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation
    Zhang, Deng Yong
    Zhu, Yan
    Wu, Qiong
    Ma, Shuoshuo
    Ma, Yang
    Shen, Zheng Chao
    Wang, Zhonglin
    Sun, Wanliang
    Zhou, Yong Chun
    Wang, Dongdong
    Zhou, Shuo
    Liu, Zhong
    Kwong, Lawrence N.
    Lu, Zheng
    CELL DEATH & DISEASE, 2023, 14 (10)
  • [50] Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway
    Hunter, Jill E.
    Campbell, Amy E.
    Hannaway, Nicola L.
    Kerridge, Scott
    Luli, Saimir
    Butterworth, Jacqueline A.
    Sellier, Helene
    Mukherjee, Reshmi
    Dhillon, Nikita
    Sudhindar, Praveen D.
    Shukla, Ruchi
    Brownridge, Philip J.
    Bell, Hayden L.
    Coxhead, Jonathan
    Taylor, Leigh
    Leary, Peter
    Hasoon, Megan S. R.
    Collins, Ian
    Garrett, Michelle D.
    Eyers, Claire E.
    Perkins, Neil D.
    BIOCHEMICAL JOURNAL, 2022, 479 (19) : 2063 - 2086